Observational study of SorbaView® 2000, SorbaView® Ultimate and SecureView® Port AFZ dressings used on Central Venous Catheters in Eleven Italian Oncology, Hematology and Pain Centers

JAVA - Journal of the Association for Vascular Access

Volumn 14, Issue 1, 2009, Pages 14-19

  Orsino, Lina ^a   Bargelli, A ^a   Cappucciati, L ^a   Fanchin, G ^a   Galati, G ^a   Manzin, F ^a   Marceca, F ^a   Pignatelli, A ^a   Peluffo, L ^a   Vendemiati, S ^a   Verze A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BANDAGES AND DRESSINGS; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CENTRAL VENOUS CATHETER; CLINICAL PROTOCOL; HEMATOLOGY; HUMAN; INFORMED CONSENT; ITALY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; ONCOLOGY; PAIN CLINIC; PLASMAPHERESIS; SKIN TOXICITY;

EID: 65249102693     PISSN: 15528855     EISSN: 15571289     Source Type: Journal    
DOI: 10.2309/java.14-1-3     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention (CDC) (2000). Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Morbidity and Mortality Weekly Report, Oct. 20, 2000, vol. 49, No. RR - 10, 1-128.
2. Garcia, R., Jendresky, L., Landesman, S., Maher, A., & Nicolas, F. (2003). Three years experience in implementing HICPAC recommendations for the reduction of central venous catheter-related bloodstream infections. Reprints of study available from Tri-State Hospital Supply Corporation, Howell, MI. Author updated continuing results: Lecture, Jan 28, 2005 APIC Tampa, FL; June 22, 2005 APIC Education Conference, Baltimore, MD; Lecture, Sept 11, 2006 AVA Convention, Indianapolis, IN. Also: What works: NY hospital uses process, product education to cut bloodstream infections. Healthcare Purchasing News. Article reprints available from Tri-State Hospital Supply Corp., Howell, MI.
3. Gillies, D., O'Riordan, E., Carr, D., O'Brien, I., Frost, J., & Gunning, R. (2003). Central venous catheter dressings: a systematic review. Journal of Advanced Nursing, 44 (6), 623-632.
4. Gillies, D., O'Riordan, E., Carr, D., Frost, J., Gunning, R., & O'Brien, I. (2003). Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database System Review, (4), CD003827; Abstract available at www.ncbi.nlm.nih.gov/pubmed/14583995.
5. Hoffmann, K.K., Weber, D.J., Samsa, G.P., & Rutala, W.A. (1992). Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of infection risks. Journal of the American Medical Association, 267,(15), 2072-2076.
6. International Nurse Counsel (2006). Optimum Quantity of Nurses for Safe Patient Care. Professioni Infermieristiche, 59(2).
7. Larson, E. (2001). Hygiene of the skin: when is clean too clean? Emerging Infectious Diseases, 7, 225-230.
8. Lee, M. (2002). Seven day dwell times for vascular access device exit site dressings. INS National Convention Poster Presentation May 7, 2002 by Michele Lee in Phoenix, AZ. Reprints of study available from Tri-State Hospital Supply Corporation, Howell, MI.
9. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al. (2002). CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections. CDC MMWR Morbidity and Mortality Weekly Report, August 9, 2002, Vol, 51, No. RR-10, 1-26.
10. Oncology Nursing Society (ONS) (2004). Access device guidelines: recommendations for nursing practice and education. 2nd ed. Pittsburgh (PA): Oncology Nursing Society (ONS), 1-141. Spiral bound booklet, Camp-Sorrell, D., editor, www.ons.org.
11. Penney-Timmons, E. (2005). Decreased Costs/Improved Outcomes With Standardized Intravenous Equipment. Journal of the Association for Vascular Access, 10, 2005, 20-23.
12. Rasero, L., Degl'Innocenti, M., Mocali, M., Alberani, R, Boschi, S., Giraudi, A., et al. (2000). Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica, 85, 275-279.
13. Shivnan, J.C., McGuire, D., Freedman, S., Sharkazy, E., Bosserman, G., Larson E., et al. (1991). A comparison of transparent adherent and dry sterile gauze dressing for long-term central catheters in patients undergoing bone marrow transplant. Oncology Nursing Forum, 18(8), 1349-1356.
14. Trotter, B.S., Brock, J.L., Schwaner, S., Conaway, M., & Burns, S.M. (2008). Central venous catheter dressings put to the test. American Nurse Today, 3(4), 43-44.
15. Winfield, C., Davis, S., Schwaner, S., Conaway, M., & Burns, S.M. (2007). Evidence: the first word in safe IV practice. American Nurse Today, 2(5), 31-33.
16. Woods, S.S., Nass, J., & Deisch, P. (2000). Selection and implementation of a transparent dressing for central vascular access devices. Nursing Clinics of North America, 35(2), 385-393.
17. Zitella, L.J., Friese, C.R., Hauser, J., Gobel, B.H., Woolery, M., O'Leary, C., et al. (2006). Putting Evidence Into Practice: Prevention of Infection. Clinical Journal of Oncology Nursing, 10(6), 739-750.